Twin pregnancy and congenital cytomegalovirus: Case report and review

References

• Nyholm JL, Schleiss MR. Prevention of maternal cytomegalovirus infection: current status and future prospects. Int J Womens Health 2010;2:23–35.
   PubMedGoogle Scholar
• Jacquemard F, Yamamoto M, Costa JM, Romand S, Jaqz-Aigrain E, Dejean A, Daffos F, Ville Y. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG 2007;114:1113–1121.
   PubMed Web of Science ®Google Scholar
• Lazzarotto T, Brojanac S, Maine GT, Landini MP. Search for cytomegalovirus-specific immunoglobulin M: comparison between a new western blot, conventional western blot, and nine commercially available assays. Clin Diagn Lab Immunol 1997;4:483–486.
   PubMedGoogle Scholar
• Revello MG, Zavattoni M, Furione M, Fabbri E, Gerna G. Preconceptional primary human cytomegalovirus infection and risk of congenital infection. J Infect Dis 2006;193:783–787.
   PubMed Web of Science ®Google Scholar
• Bodéus M, Hubinont C, Goubau P. Increased risk of cytomegalovirus transmission in utero during late gestation. Obstet Gynecol 1999;93:658–660.
   PubMed Web of Science ®Google Scholar
• Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992;326:663–667.
   PubMed Web of Science ®Google Scholar
• Karltorp E, Hellström S, Lewensohn-Fuchs I, Carlsson-Hansén E, Carlsson PI, Engman ML. Congenital cytomegalovirus infection - a common cause of hearing loss of unknown aetiology. Acta Paediatr 2012;101:e357–e362.
   Google Scholar
• Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol 2006;35:216–220.
   PubMed Web of Science ®Google Scholar
• Adler SP, Nigro G. Findings and conclusions from CMV hyperimmune globulin treatment trials. J Clin Virol 2009;46 Suppl 4:S54–S57.
   Google Scholar
• Nigro G, Adler SP, Parruti G, Anceschi MM, Coclite E, Pezone I, Di Renzo GC. Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy–a case-control study of the outcome in children. J Infect Dis 2012;205:215–227.
   PubMed Web of Science ®Google Scholar
• Lazzarotto T, Spezzacatena P, Pradelli P, Abate DA, Varani S, Landini MP. Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects. Clin Diagn Lab Immunol 1997;4:469–473.
   PubMedGoogle Scholar
• Nigro G, Adler SP, Gatta E, Mascaretti G, Megaloikonomou A, Torre RL, Necozione S. Fetal hyperechogenic bowel may indicate congenital cytomegalovirus disease responsive to immunoglobulin therapy. J Matern Fetal Neonatal Med 2012;25:2202–2205.
   PubMed Web of Science ®Google Scholar
• Guerra B, Simonazzi G, Puccetti C, Lanari M, Farina A, Lazzarotto T, Rizzo N. Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 2008;198:380.e1–380.e7.
   Web of Science ®Google Scholar
• Mazza V, Pati M, Bertucci E, Re C, Ranzi A, Percesepe A, Forabosco A, Volpe A. Age-specific risk of fetal loss post second trimester amniocentesis: analysis of 5043 cases. Prenat Diagn 2007;27:180–183.
   PubMed Web of Science ®Google Scholar
• Bodéus M, Hubinont C, Bernard P, Bouckaert A, Thomas K, Goubau P. Prenatal diagnosis of human cytomegalovirus by culture and polymerase chain reaction: 98 pregnancies leading to congenital infection. Prenat Diagn 1999;19:314–317.
   PubMed Web of Science ®Google Scholar
• Enders G, Bäder U, Lindemann L, Schalasta G, Daiminger A. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn 2001;21:362–377.
   PubMed Web of Science ®Google Scholar
• Biron KK. Antiviral drugs for cytomegalovirus diseases. Antiviral Res 2006;71:154–163.
   PubMed Web of Science ®Google Scholar
• Keller MA, Stiehm ER. Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev 2000;13:602–614.
   PubMed Web of Science ®Google Scholar
• Bratcher DF, Bourne N, Bravo FJ, Schleiss MR, Slaoui M, Myers MG, Bernstein DI. Effect of passive antibody on congenital cytomegalovirus infection in guinea pigs. J Infect Dis 1995;172:944–950.
   PubMed Web of Science ®Google Scholar
• Nigro G, Adler SP, La Torre R, Best AM; Congenital Cytomegalovirus Collaborating Group. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005;353:1350–1362.
   PubMed Web of Science ®Google Scholar
• Nigro G, Torre RL, Pentimalli H, Taverna P, Lituania M, de Tejada BM, Adler SP. Regression of fetal cerebral abnormalities by primary cytomegalovirus infection following hyperimmunoglobulin therapy. Prenat Diagn 2008;28:512–517.
   PubMed Web of Science ®Google Scholar
• Nigro G, Torre RL, Pentimalli H, Taverna P, Lituania M, de Tejada BM, Adler SP. Regression of fetal cerebral abnormalities by primary cytomegalovirus infection following hyperimmunoglobulin therapy. Prenat Diagn 2008;28:512–517.
   PubMed Web of Science ®Google Scholar
• Visentin S, Manara R, Milanese L, Da Roit A, Forner G, Salviato E, Citton V, et al. Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age. Clin Infect Dis 2012;55:497–503.
   PubMed Web of Science ®Google Scholar
• Moxley K, Knudtson EJ. Resolution of hydrops secondary to cytomegalovirus after maternal and fetal treatment with human cytomegalovirus hyperimmune globulin. Obstet Gynecol 2008;111:524–526.
   PubMed Web of Science ®Google Scholar